( (S (NP-SBJ-1 (NNP Lopid) (NNS sales)) (VP (VBP are) (VP (VBN expected) (S (NP-SBJ (-NONE- *-1)) (VP (TO to) (VP (VB be) (NP-PRD (QP (RB about) ($ $) (CD 300) (CD million)) (-NONE- *U*)) (NP-TMP (DT this) (NN year)) (, ,) (ADVP (RB up) (PP (IN from) (NP (QP ($ $) (CD 190) (CD million)) (-NONE- *U*)) (PP-TMP (IN in) (NP (CD 1988)))))))))) (. .)))
( (S (PP-LOC (IN In) (NP (NP (NNP Morris) (NNP Plains)) (, ,) (NP (NNP N.J.)) (, ,))) (NP-SBJ (NP (DT a) (NN spokesman)) (PP (IN for) (NP (DT the) (NN company)))) (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ (NP (DT the) (NNS analysts) (POS ')) (NNS projections)) (VP (VBP are) (`` ``) (PP-LOC-PRD (IN in) (NP (DT the) (NN ballpark))))))) (. .) ('' '')))
( (S (NP-SBJ-2 (NP (NNP Squibb) (POS 's)) (NN profit)) (, ,) (S-ADV (NP-SBJ-3 (-NONE- *-2)) (VP (VBN estimated) (PP (IN by) (NP-LGS (NNS analysts))) (S (NP-SBJ (-NONE- *-3)) (VP (TO to) (VP (VB be) (PP-LOC-PRD (NP (QP (RB about) (CD 18)) (NN %)) (IN above) (NP (NP (NP (DT the) (QP ($ $) (CD 123) (CD million)) (-NONE- *U*)) (, ,) (CC or) (NP (NP ($ $) (CD 1.25) (-NONE- *U*)) (NP-ADV (DT a) (NN share)))) (, ,) (SBAR (WHNP-1 (-NONE- 0)) (S (NP-SBJ (PRP it)) (VP (VBD earned) (NP (-NONE- *T*-1)) (PP-TMP (IN in) (NP (NP (DT the) (JJ third) (NN quarter)) (PP (IN of) (NP (CD 1988)))))))) (, ,)))))))) (VP (VBD was) (NP-PRD (NP (DT the) (NN result)) (PP (IN of) (NP (NP (ADJP (RB especially) (JJ strong)) (NNS sales)) (PP (IN of) (NP (NP (PRP$ its) (NNP Capoten) (NN drug)) (PP (IN for) (S-NOM (NP-SBJ (-NONE- *)) (VP (VBG treating) (NP (NP (JJ high) (NN blood) (NN pressure)) (CC and) (NP (JJ other) (NN heart) (NN disease)))))))))))) (. .)))
( (S (NP-SBJ-1 (DT The) (NN company)) (VP (VBD was) (VP (ADVP-MNR (RB officially)) (VBN merged) (NP (-NONE- *-1)) (PP-CLR (IN with) (NP (NNP Bristol-Myers) (NNP Co.))) (NP-TMP (RBR earlier) (DT this) (NN month)))) (. .)))
( (S (NP-SBJ-1 (NNP Bristol-Myers)) (VP (VBD declined) (S (NP-SBJ (-NONE- *-1)) (VP (TO to) (VP (VB comment))))) (. .)))
( (S (NP-SBJ (NP (NNP Mr.) (NNP Riccardo)) (PP (IN of) (NP (NNP Bear) (NNP Stearns)))) (VP (VBD said) (SBAR (IN that) (S (NP-SBJ (NP (NP (NP (NNP Schering-Plough) (NNP Corp.) (POS 's)) (JJ expected) (NN profit) (NN rise)) (PP (IN of) (NP (QP (RB about) (CD 18) (NN %) (TO to) (CD 20) (NN %)) (-NONE- *U*)))) (, ,) (CC and) (NP (NP (NP (NNP Bristol-Meyers) (POS 's)) (JJ expected) (NN profit) (NN increase)) (PP (IN of) (NP (QP (RB about) (CD 13)) (NN %))))) (VP (VBP are) (SBAR-PRP-PRD (ADVP (RB largely)) (IN because) (`` ``) (S (NP-SBJ-1 (DT those) (NNS companies)) (VP (VBP are) (ADVP (RB really)) (VP (VBN managed) (NP (-NONE- *-1)) (ADVP-MNR (RB well)))))))))) (. .) ('' '')))
( (S (NP-SBJ (NN ScheringPlough)) (VP (VBD earned) (NP (NP (QP ($ $) (CD 94.4) (CD million)) (-NONE- *U*)) (, ,) (CC or) (NP (NP (CD 84) (NNS cents)) (NP-ADV (DT a) (NN share)))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NNP Bristol-Myers)) (VP (VBD earned) (NP (NP (QP ($ $) (CD 232.3) (CD million)) (-NONE- *U*)) (, ,) (CC or) (NP (NP (CD 81) (NNS cents)) (NP-ADV (DT a) (NN share)))) (, ,) (PP-TMP (IN in) (NP (NP (DT the) (JJ like) (NN period)) (ADVP-TMP (NP (DT a) (NN year)) (RBR earlier)))))))) (. .)))
( (S (PP-LOC (IN In) (NP (NP (NNP Madison)) (, ,) (NP (NNP N.J.)))) (, ,) (NP-SBJ (NP (DT a) (NN spokesman)) (PP (IN for) (NP (NNP Schering-Plough)))) (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ (DT the) (NN company)) (VP (VBZ has) (NP (`` ``) (NP (DT no) (NNS problems)) ('' '') (PP (IN with) (NP (NP (DT the) (JJ average) (NN estimate) (SBAR (-NONE- *ICH*-1))) (PP (IN by) (NP (DT a) (NNS analysts))) (SBAR-1 (IN that) (S (NP-SBJ (NP (JJ third-quarter) (NNS earnings)) (PP (IN per) (NP (NN share)))) (VP (VBD rose) (PP-EXT (IN by) (NP (QP (RB about) (CD 19)) (NN %))) (, ,) (PP-DIR (TO to) (NP ($ $) (CD 1) (-NONE- *U*))))))))))))) (. .)))
( (S (S-TPC-2 (NP-SBJ-1 (DT The) (NN company)) (VP (VBZ expects) (S (NP-SBJ (-NONE- *-1)) (VP (TO to) (VP (VB achieve) (NP (NP (DT the) (ADJP (CD 20) (NN %)) (NN increase)) (PP-LOC (IN in) (NP (JJ full-year) (NNS earnings))) (PP (IN per) (NP (NN share)))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ (PRP it)) (VP (VBD projected) (PP (IN in) (NP (DT the) (NN spring))))))))))) (, ,) (NP-SBJ (DT the) (NN spokesman)) (VP (VBD said) (SBAR (-NONE- 0) (S (-NONE- *T*-2)))) (. .)))
( (S (ADVP-TMP (RB Meanwhile)) (, ,) (NP-SBJ (NNS analysts)) (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ (NP (NP (NNP Pfizer) (POS 's)) (JJ recent) (NN string)) (PP (IN of) (NP (JJ lackluster) (JJ quarterly) (NNS performances)))) (VP (VBD continued) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-1 (NP (NNS earnings)) (PP-TMP (IN in) (NP (DT the) (NN quarter)))) (VP (VBD were) (VP (VBN expected) (S (NP-SBJ (-NONE- *-1)) (VP (TO to) (VP (VB decline) (PP-EXT (IN by) (NP (QP (RB about) (CD 5)) (NN %)))))))))))))) (. .)))
( (S (NP-SBJ (NP (NNP Sales)) (PP (IN of) (NP (NP (NP (NNP Pfizer) (POS 's)) (JJ important) (NNS drugs)) (, ,) (NP (NP (NP (NNP Feldene)) (PP (IN for) (S-NOM (NP-SBJ (-NONE- *)) (VP (VBG treating) (NP (NN arthritis)))))) (, ,) (CC and) (NP (NP (NNP Procardia)) (, ,) (NP (DT a) (NN heart) (NN medicine)) (, ,)))))) (VP (VBP have) (VP (VBN shrunk) (PP-PRP (RB because) (IN of) (NP (JJ increased) (NN competition))))) (. .)))
( (S (`` ``) (S-TPC-1 (NP-SBJ (DT The) (PRN (-LRB- -LRB-) (JJ strong) (-RRB- -RRB-)) (NN dollar)) (VP (VBD hurt) (NP (NNP Pfizer)) (NP-ADV (DT a) (NN lot)) (, ,) (ADVP (RB too)))) (, ,) ('' '') (NP-SBJ (NNP Mr.) (NNP Sweig)) (VP (VBD said) (S (-NONE- *T*-1))) (. .)))
( (S (PP-TMP (IN In) (NP (DT the) (JJ third) (NN quarter))) (NP-TMP (JJ last) (NN year)) (, ,) (NP-SBJ (NNP Pfizer)) (VP (VBD earned) (NP (NP (QP ($ $) (CD 216.8) (CD million)) (-NONE- *U*)) (, ,) (CC or) (NP (NP ($ $) (CD 1.29) (-NONE- *U*)) (NP-ADV (DT a) (NN share))))) (. .)))
( (S (PP-LOC (IN In) (NP (NNP New) (NNP York))) (, ,) (NP-SBJ (DT the) (NN company)) (VP (VBD declined) (NP (NN comment))) (. .)))
( (S (NP-SBJ (NNS Analysts)) (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ (PRP they)) (VP (VBD expected) (S (NP-SBJ (NP (NNP Upjohn) (POS 's)) (NN profit)) (VP (TO to) (VP (VP (VB be) (ADJP-PRD (JJ flat))) (CC or) (VP (VB rise) (PP-EXT (IN by) (NP (NP (QP (RB only) (RB about) (CD 2) (NN %) (TO to) (CD 4) (NN %)) (-NONE- *U*)) (SBAR (IN as) (S (NP-SBJ-2 (-NONE- *)) (VP (VBN compared) (NP (-NONE- *-2)) (PP-CLR (IN with) (NP (NP (NP (QP ($ $) (CD 89.6) (CD million)) (-NONE- *U*)) (, ,) (CC or) (NP (NP (CD 49) (NNS cents)) (NP-ADV (DT a) (NN share)))) (, ,) (SBAR (WHNP-1 (-NONE- 0)) (S (NP-SBJ (PRP it)) (VP (VBD earned) (NP (-NONE- *T*-1)) (ADVP-TMP (NP (DT a) (NN year)) (RB ago)))))))))))))))))))) (. .)))
( (S (NP-SBJ (NP (NNP Upjohn) (POS 's)) (JJ biggest-selling) (NNS drugs)) (VP (VBP are) (NP-PRD (NP (NP (NNP Xanax)) (, ,) (NP (DT a) (NN tranquilizer))) (, ,) (CC and) (NP (NP (NNP Halcion)) (, ,) (NP (DT a) (NN sedative))))) (. .)))
( (S (NP-SBJ-1 (NP (NNS Sales)) (PP (IN of) (NP (DT both) (NNS drugs)))) (VP (VBP have) (VP (VBN been) (VP (VBN hurt) (NP (-NONE- *-1)) (PP (IN by) (NP-LGS (NP (NP (JJ new) (NN state) (NNS laws)) (VP (VBG restricting) (NP (NP (DT the) (NNS prescriptions)) (PP (IN of) (NP (JJ certain) (JJ tranquilizing) (NNS medicines)))))) (CC and) (NP (NP (JJ adverse) (NN publicity)) (PP (IN about) (NP (NP (DT the) (JJ excessive) (NN use)) (PP (IN of) (NP (DT the) (NNS drugs))))))))))) (. .)))
( (S (S-TPC-2 (ADVP (RB Also)) (, ,) (S (NP-SBJ (NP (NP (DT the) (NN company) (POS 's)) (JJ hair-growing) (NN drug)) (, ,) (NP (NNP Rogaine)) (, ,)) (VP (VBZ is) (VP (VBG selling) (ADVP-MNR (RB well)) (: --) (PP (IN at) (NP (NP (QP (RB about) ($ $) (CD 125) (CD million)) (-NONE- *U*)) (PP (IN for) (NP (DT the) (NN year)))))))) (, ,) (CC but) (S (NP-SBJ-1 (NP (NP (DT the) (NN company) (POS 's)) (NN profit)) (PP (IN from) (NP (DT the) (NN drug)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reduced) (NP (-NONE- *-1)) (PP (IN by) (NP-LGS (NP (NP (NNP Upjohn) (POS 's)) (JJ expensive) (NN print) (CC and) (NN television) (NNS campaigns)) (PP (IN for) (NP (VBG advertising)))))))))) (, ,) (NP-SBJ (NNS analysts)) (VP (VBD said) (SBAR (-NONE- 0) (S (-NONE- *T*-2)))) (. .)))
( (S (PP-LOC (IN In) (NP (NP (NNP Kalamazoo)) (, ,) (NP (NNP Mich.)) (, ,))) (NP-SBJ (NNP Upjohn)) (VP (VBD declined) (NP (NN comment))) (. .)))
( (S (PP-LOC (IN Amid) (NP (NP (DT a) (NN crowd)) (PP (IN of) (NP (VBG crashing) (NNS stocks))))) (, ,) (NP-SBJ-2 (NP (NNP Relational) (NNP Technology) (NNP Inc.) (POS 's)) (NN stock)) (VP (VBD fell) (ADVP-MNR (RB particularly) (RB hard)) (NP-TMP (NNP Friday)) (, ,) (S-ADV (NP-SBJ (-NONE- *-2)) (VP (VBG dropping) (NP-EXT (CD 23) (NN %)) (SBAR-PRP (IN because) (S (NP-SBJ-1 (PRP$ its) (NNS problems)) (VP (VBD were) (VP (VBN compounded) (NP (-NONE- *-1)) (PP (IN by) (NP-LGS (NP (NN disclosure)) (PP (IN of) (NP (NP (DT an) (JJ unexpected) (NN loss)) (PP (IN for) (NP (PRP$ its) (JJ fiscal) (JJ first) (NN quarter)))))))))))))) (. .)))
( (S (NP-SBJ (DT The) (NN database) (NN software) (NN company)) (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ (PRP it)) (VP (VBZ expects) (NP (NP (DT a) (ADJP (QP ($ $) (CD 2) (CD million)) (-NONE- *U*)) (JJ net) (NN loss)) (PP (IN for) (NP (NP (DT the) (JJ fiscal) (JJ first) (NN quarter)) (VP (VBN ended) (NP-TMP (NNP Sept.) (CD 30)))))))))) (. .)))
( (S (NP-SBJ (PRP It)) (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ (NNS analysts)) (VP (VBD had) (VP (VBN been) (VP (VBG expecting) (NP (NP (DT a) (JJ small) (NN profit)) (PP (IN for) (NP (DT the) (NN period)))))))))) (. .)))
( (S (NP-SBJ-1 (NN Revenue)) (VP (VBZ is) (VP (VBN expected) (S (NP-SBJ (-NONE- *-1)) (VP (TO to) (VP (VB be) (ADVP-PRD (`` ``) (RB up) (RB modestly) ('' '') (PP (IN from) (NP (NP (DT the) (QP ($ $) (CD 26.5) (CD million)) (-NONE- *U*)) (VP (VBN reported) (NP (-NONE- *)) (ADVP-TMP (NP (DT a) (NN year)) (RB ago))))))))))) (. .)))
( (S (NP-SBJ (NNP Relational) (NNP Technology)) (VP (VBD reported) (NP (NP (JJ net) (NN income)) (PP (IN of) (NP (NP (QP ($ $) (CD 1.5) (CD million)) (-NONE- *U*)) (, ,) (CC or) (NP (NP (CD 12) (NNS cents)) (NP-ADV (DT a) (NN share))))) (, ,) (PP-TMP (IN in) (NP (DT the) (JJ year-earlier) (NN period))))) (. .)))
( (SINV (`` ``) (S-TPC-1 (SBAR-ADV (IN While) (S (NP-SBJ (PRP$ our) (JJ international) (NNS operations)) (VP (VBD showed) (NP (JJ strong) (NN growth))))) (, ,) (NP-SBJ (PRP$ our) (JJ domestic) (NN business)) (VP (VBD was) (PP-LOC-PRD (ADVP (RB substantially)) (IN below) (NP (NNS expectations))))) (, ,) ('' '') (VP (VBD said) (S (-NONE- *T*-1))) (NP-SBJ (NP (NNP Paul) (NNP Newton)) (, ,) (NP (NP (NN president)) (CC and) (NP (JJ chief) (JJ executive) (NN officer)))) (. .)))
( (S (NP-SBJ (DT A) (NN spokesman)) (VP (VBD said) (SBAR (SBAR (-NONE- 0) (S (NP-SBJ (NP (DT the) (NN company) (POS 's)) (JJ first) (NN quarter)) (VP (VBZ is) (ADJP-PRD (RB historically) (JJ soft))))) (, ,) (CC and) (SBAR (-NONE- 0) (S (NP-SBJ (NP (NN computer) (NNS companies)) (PP (IN in) (ADJP (JJ general)))) (VP (VBP are) (VP (VBG experiencing) (NP (JJR slower) (NNS sales)))))))) (. .)))
( (S (NP-SBJ (NNP Mr.) (NNP Newton)) (VP (VBD said) (SBAR (SBAR (-NONE- 0) (S (NP-SBJ (PRP he)) (VP (VBD accepted) (NP (NP (DT the) (NN resignation)) (PP (IN of) (NP (NP (NNP Thomas) (NNP Wilson)) (, ,) (NP (NP (NN vice) (NN president)) (PP (IN of) (NP (JJ corporate) (NNS sales)))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP-SBJ-1 (PRP$ his) (NN marketing) (NNS responsibilities)) (VP (VBP have) (VP (VBN been) (VP (VBN reassigned) (NP (-NONE- *-1))))))))) (. .)))
( (S (NP-SBJ (DT The) (NN company)) (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ (NP (NNP Mr.) (NNP Wilson) (POS 's)) (NN resignation)) (VP (VBD was) (RB n't) (ADJP-PRD (VBN related) (PP (TO to) (NP (DT the) (NNS sales) (NN shortfall)))))))) (. .)))
( (S (NP-SBJ (NNP Relational) (NNP Technology)) (VP (VBD went) (NP-PRD (NN public)) (PP-TMP (IN in) (NP (NNP May) (CD 1988))) (PP (IN at) (NP (NP ($ $) (CD 14) (-NONE- *U*)) (NP-ADV (DT a) (NN share))))) (. .)))
( (S (NP-SBJ (PRP It)) (VP (VBD fell) (NP-EXT (NP ($ $) (CD 1.875) (-NONE- *U*)) (NP-ADV (DT a) (NN share))) (NP-TMP (NNP Friday)) (, ,) (PP-DIR (TO to) (NP (NP ($ $) (CD 6.25) (-NONE- *U*)) (, ,) (NP (DT a) (JJ new) (JJ low)))) (, ,) (PP-LOC (IN in) (NP (JJ over-the-counter) (NN trading)))) (. .)))
( (S (NP-SBJ (NP (PRP$ Its) (NN high)) (PP (IN for) (NP (DT the) (JJ past) (NN year)))) (VP (VBD was) (NP-PRD (NP ($ $) (CD 16.375) (-NONE- *U*)) (NP-ADV (DT a) (NN share)))) (. .)))
